Differences in COPD-related readmissions to primary and secondary care hospitals

Scandinavian Journal of Primary Health Care

Volumn 27, Issue 2, 2009, Pages 80-84

  Lampela, Pekka ^a,e   Säynäjäkangas, Olli ^b   Jokelainen, Jari ^c   Keistinen, Timo ^c,d  

^a Rovaniemi Health Centre   (Finland)

^b LAPLAND CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d Vaasa Health Care Region   (Finland)

^e NONE   (Finland)

Author keywords

Acute exacerbation; Chronic obstructive pulmonary disease; Family practice; General practice; Hospitalization; Readmission

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; EMERGENCY CARE; FEMALE; FINLAND; HEALTH CARE QUALITY; HEART FAILURE; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY HEALTH CARE; REGISTER; RESPIRATORY TRACT INFECTION; RISK FACTOR; ACUTE DISEASE; CHRONIC DISEASE; COMPARATIVE STUDY; EMERGENCY; GENERAL PRACTICE; LENGTH OF STAY; MIDDLE AGED; OUTCOME ASSESSMENT;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; EMERGENCIES; FAMILY PRACTICE; FEMALE; FINLAND; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; RISK FACTORS;

EID: 66149138005     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.1080/02813430802673501     Document Type: Article

References (24)

1. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117:5S-9S.
2. Miravitlles M, Mayordomo C, Artes M, Sanchez-Agudo L, Nicolau F, Segu JL. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitacion Obstructiva al Flujo aEreo. Respir Med 1999;93:173-9.
3. Westert GP, Lagoe RJ, Keskimäki I, Leyland A, Murphy M. An international study of hospital readmissions and related utilization in Europe and the USA. Health Policy 2002;61: 269-78.
4. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006;11:188-95.
5. Almagro P, Barreiro B, Ochoa de EA, Quintana S, Rodriguez CM, Heredia JL, et al. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 2006;73:311-7.
6. Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002;57:137-41.
7. Lampela P, Säynäjakangas O, Keistinen T Is the treatment of acute COPD exacerbations in Finland shifting to general practitioners? Scand J Prim Health Care 2006;24:140-4.
8. Keskimäki I, Aro S. Accuracy of data on diagnoses, procedures and accidents in the Finnish Hospital Discharge Register. Int Health Sciences 2003;2:15-21.
9. Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immo-nen-Raiha P, Karja-Koskenkari P, et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005;12:132-7.
10. Pietinalho A, Kinnula VL, Sovijarvi AR, Vilkman S, Säynäjä kangas O, Liippo K, et al. Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report. Respir Med 2007;101:1419-25.
11. Burge S, Wedzicha JA. COPD exacerbations: Definitions and classifications. Eur Respir J Suppl 2003;41:46s-53s.
12. White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease, 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 2003;58: 73-80.
13. Price LC, Lowe D, Hosker HS, Anstey K, Pearson MG, Roberts CM. UK National COPD Audit 20 03: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 2006;61:837-42.
14. Jimenez PA, Fernandez GJ, Hidalgo RL, Domingo GS, Lara BA, Garcia AJ. Quality of inpatient care and risk of early readmission in acute exacerbation of COPD. Ann Med Int 2003;20:340-6.
15. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154:407-12.
16. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2007. Available at: http:// www.goldcopd.org.
17. Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: A European survey. Eur Respir J 1996;9:1590-5.
18. Oostenbrink JB, Rutten-van Molken MP, Al MJ, Van Noord JA, Vincken W. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease. Eur Respir J 2004;23:241-9.
19. Soriano JB, Kiri VA, Pride NB, Vestbo J. Inhaled corticosteroids with/without long-acting beta-agonists reduce the risk of rehospitalization and death in COPD patients. Am J Respir Med 2003;2:67-74.
20. National Agency for Medicines. Finnish Medication Statistics 2004. Available at: http://www.nam.fi/uploads/laakeku lutus/KS-SLT2004.pdf.
21. Davies L, Wilkinson M, Bonner S, Calverley PM, Angus RM. "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. BMJ 2000;321: 1265-8.
22. Sin DD, Bell NR, Svenson LW, Man SF. The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: A population-based study. Am J Med 2002;112: 120-5.
23. Bourbeau J, Collet JP, Schwartzman K, Ducruet T, Nault D, Bradley C, et al. Economic benefits of self-management education in COPD. Chest 2006;130:1704-11.
24. Smith BJ, Dalziel K, McElroy HJ, Ruffin RE, Frith PA, McCaul KA, et al. Barriers to success for an evidence-based guideline for chronic obstructive pulmonary disease. Chron Respir Dis 2005;2:121-31.